UMB Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
UMB Bank's NVS Position: Q2 2026 in Review
UMB Bank reduced its Novartis (NVS) stake by 1.4% in Q2 2026, selling an estimated $13.9K and leaving 6,571 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #361.
UMB Bank first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.23M in Q2 2023. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- UMB Bank held 6,571 shares of Novartis worth $1.03M as of Q2 2026.
- UMB Bank sold 93 Novartis shares in Q2 2026, an estimated $13.9K.
- Novartis made up 0.01% of UMB Bank's portfolio in Q2 2026, its #361 holding.
- UMB Bank first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
- UMB Bank's Novartis position peaked at $1.23M in Q2 2023.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.